Back to articles
Comparative guide · 6 min read

Tongkat Ali vs Fadogia Agrestis — what does the human evidence actually look like?

Updated 2026-05-10 · Reviewed by SupplementScore editors · No sponsorships

Both became podcast-famous as a "natural T-boost stack" in the early 2020s. The actual human evidence is asymmetric: tongkat ali has a small but real clinical trial base for free testosterone effects in hypogonadal men. Fadogia agrestis has effectively no human clinical trial data — what's published is rodent studies and one anecdotal protocol. Treating them as equivalent options is treating a published Phase 2 trial as the same thing as a tweet.

Quick verdict

GoalBetter choiceWhy
Modest free testosterone increase in low-T men Tongkat ali (standardised) Multiple small RCTs at 200–400 mg/day of standardised extract show modest increases in free testosterone in hypogonadal men.
Stress / fatigue in middle-aged men Tongkat ali Talbott 2013 showed reductions in cortisol-to-testosterone ratio and improved subjective stress in stressed adults.
Total testosterone in eugonadal (normal-T) men Neither Neither has demonstrated reliable total-T elevation in men with already-normal levels.
Libido in men with diagnosed hypogonadism Tongkat ali (modest) Some signal in trial-cited preparations; not a substitute for endocrine workup.
Lean mass / strength gains Neither (use creatine + protein + training) Neither has trial weight comparable to creatine + adequate protein + structured progressive overload.
"I want to be optimised" Look at sleep, weight, training first Almost all of the variance in healthy-young-male testosterone comes from sleep, body fat, training, and not chronically under-eating.

How they compare on the things that matter

Mechanism — proposed vs demonstrated

Tongkat ali (Eurycoma longifolia, "longjack") contains quassinoids and the marker compound eurycomanone. The proposed mechanism for testosterone effects is reduced sex-hormone binding globulin (SHBG) — freeing up bound testosterone — and possibly direct steroidogenic effects in the Leydig cells. The trial-cited preparation is a water-based standardised root extract, often referred to in trials as "LJ100" or simply "standardised tongkat ali extract."

Fadogia agrestis is a Nigerian shrub. The proposed mechanism is luteinising-hormone (LH)-mediated stimulation of testicular testosterone production. This proposal rests almost entirely on a 2005 rat study (Yakubu et al.) showing increased serum testosterone after aqueous stem extract administration. There are no published randomised controlled trials of fadogia agrestis in humans for any endpoint as of this writing.

Evidence base by clinical endpoint

Read this before starting either. If your concern is "I think I have low testosterone," the right move is a morning serum total testosterone (and free T, SHBG, LH) measurement, not a supplement protocol. Self-treating undiagnosed low T with herbal stacks delays workup of pituitary, testicular, or systemic causes that have specific treatments.

Dose and form

For tongkat ali, the trial-cited dose is 200–400 mg/day of a water-based, standardised root extract — Physta or similar — taken in the morning. The eurycomanone content matters; products without an assayed bioactive content are essentially uncharacterised. Effects build over 4–12 weeks; assessment before that window is meaningless. Cycle 5 days on, 2 days off is sometimes recommended but lacks trial support — daily dosing is what most trials used.

For fadogia agrestis, popular podcast protocols recommend 600 mg/day of dried stem powder for 8 weeks, off for 2–4 weeks. There is no clinical trial standard; manufacturers vary wildly in source and standardisation; you are essentially self-experimenting.

Safety

Tongkat ali has reasonably well-characterised short-term human safety. Rare reports of mild GI upset and insomnia at higher doses. The main caveat is heavy-metal contamination — historical batches from less reputable suppliers have shown elevated mercury and lead. Buy from suppliers that publish certificates of analysis. Discuss with a clinician if you take antidiabetic medications (theoretical additive hypoglycaemia) or have a hormone-sensitive cancer history.

Fadogia agrestis safety is essentially uncharacterised in humans. Rodent studies have shown testicular toxicity at higher doses (paradoxically — high-dose Fadogia in rats has caused histological testicular damage). Whether that translates to humans at podcast-protocol doses is unknown. Liver-function abnormalities have been reported anecdotally.

What the price difference buys you

Tongkat ali (standardised) runs roughly $20–40/month at trial-cited doses. Fadogia runs $20–35/month at common protocol doses. The combination "T-boost stacks" frequently bundle both at sub-therapeutic doses plus zinc, vitamin D, ashwagandha, and various honourable mentions for $60–90/month — generally not a good deal vs. running individual standardised products if you decide to use them at all.

Who should skip each

Both should be avoided in pregnancy, lactation, and adolescence. Avoid tongkat ali if you have hormone-sensitive cancer history without explicit oncology sign-off. Avoid fadogia agrestis if you have any liver disease, are on hepatotoxic medications, or simply want a supplement with characterised human safety data.

What we'd actually buy

For documented low free testosterone with stress / fatigue presentation, after appropriate medical workup: standardised tongkat ali extract 200 mg/day for an 8–12 week trial with repeat labs.

For fadogia agrestis: we wouldn't, until human trials exist. The risk-evidence ratio for self-experimentation with a compound that has rodent testicular-toxicity signals is wrong, regardless of what podcasts say.

For "general male optimisation" without a diagnosis: prioritise sleep duration and quality, body composition, resistance training, and adequate dietary energy and protein intake. The marginal effect of any of these dwarfs anything a botanical does in a healthy young or middle-aged man.

Sources

Read more: